Skip to content

MEDILIFE FUNCTION

Active
Private limited companyfounded 20232 yrs activeLisalastraat 32, 1190 Vorst, BelgiumKBO/BCE: BE 1001.941.209
Summary

The computed 12-month bankruptcy probability of MEDILIFE FUNCTION is 5.1% (elevated). The 2024 annual accounts show equity of €44,439 and a net result of €40,439. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
59 / 100
Fair
An elevated bankruptcy probability caps the score. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
5.1% Elevated
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,500 at 30 days only on tighter terms
Liquidity ample (current ratio 4.3; short-term debt: 22.6% and cash: 22.2% of total assets), and 22.6% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 22-09-2025, 53 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2024
53 d late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its 2024 accounts 53 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

MEDILIFE FUNCTION was incorporated on 6 November 2023 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€44,439
Total assets
€57,428
Net result
€40,439
Working capital
€42,808

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €57,428
Fixed assets €1,631
Current assets €55,797
Equity and liabilities €57,428
Equity €44,439
Debt €12,990
Debt finances 22.6% of the balance-sheet total.
Key figures and ratios
2024 value
EBITDA
€52,034
Cash flow
€40,746
Current ratio
4.30
Debt to equity
0.29
ROE
91.0%
ROA
70.4%
Interest coverage
2522.27
Debt ≤ 1 year
€12,990
Income taxes
€12,037

Peer companies

Historical observation

Of the 39,276 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
2.2% stopped otherwise
96% still going

A further 0.5% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a higher bankruptcy probability: 5.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,276 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 · 36 lines
Balance sheet Code2024
Assets
Total assets20/58€57,428
Fixed assets21/28€1,631
Tangible fixed assets22/27€1,631
Plant, machinery and equipment23€1,631
Current assets29/58€55,797
Amounts receivable within one year40/41€32,273
Other amounts receivable41€32,273
Current investments50/53€10,000
Cash at bank and in hand54/58€12,755
Deferred charges and accrued income490/1€769
Equity and liabilities
Total equity and liabilities10/49€57,428
Equity10/15€44,439
Contributions10/11€4,000
Reserves13€40,439
Distributable reserves133€40,439
Amounts payable17/49€12,990
Amounts payable within one year42/48€12,990
Trade debts44€952
Suppliers440/4€952
Taxes, remuneration and social security45€12,037
Taxes450/3€12,037
Income statement Code2024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€307
Other operating charges640/8€81
Gross operating margin9900€52,116
Operating profit (loss)9901€51,727
Financial income75/76B€769
Recurring financial income75€769
Financial charges65/66B€21
Recurring financial charges65€21
Profit (loss) for the period before taxes9903€52,476
Income taxes67/77€12,037
Profit (loss) for the period9904€40,439
Profit (loss) for the period to be appropriated9905€40,439
Appropriation of the result
Profit (loss) to be appropriated9906€40,439
Transfer to equity691/2€40,439
To other reserves6921€40,439

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€307
Other operating charges640/8€81
Gross operating margin9900€52,116
Operating profit (loss)9901€51,727
Financial income75/76B€769
Recurring financial income75€769
Financial charges65/66B€21
Recurring financial charges65€21
Profit (loss) for the period before taxes9903€52,476
Income taxes67/77€12,037
Profit (loss) for the period9904€40,439
Profit (loss) for the period to be appropriated9905€40,439
Line2024
Assets
Total assets20/58€57,428
Fixed assets21/28€1,631
Tangible fixed assets22/27€1,631
Plant, machinery and equipment23€1,631
Current assets29/58€55,797
Amounts receivable within one year40/41€32,273
Other amounts receivable41€32,273
Current investments50/53€10,000
Cash at bank and in hand54/58€12,755
Deferred charges and accrued income490/1€769
Equity and liabilities
Total equity and liabilities10/49€57,428
Equity10/15€44,439
Contributions10/11€4,000
Reserves13€40,439
Distributable reserves133€40,439
Amounts payable17/49€12,990
Amounts payable within one year42/48€12,990
Trade debts44€952
Suppliers440/4€952
Taxes, remuneration and social security45€12,037
Taxes450/3€12,037
Line2024
Profit (loss) for the period9904€40,439
+ Depreciation and write-downs630€307
Operating cash flow (approximation)€40,746

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
22-09
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 53 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Vorst · 1 establishment unit since 2023
seat establishment The establishment unit on the map
Ground area
1,082 m²
Building footprint
404 m²
Volume, LiDAR
5,288 m³
Parcel 21384D0087/00F009, Brussels · tallest building 16.4 m, ±5 floors. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
MEDILIFE FUNCTION
Lisalastraat 32, 1190 VorstSpecialist medical practice
since 20232.352.152.604
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21384D0087/00F009 Brussels 1,082 m² 1 · 404 m² 16.4 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

254900JZK9V589XXMC27
live in the LEI register

Identification & contact

Identification
Legal formPrivate limited company
Founded06-11-2023
Fiscal year end31-12
Contact
E-mail jonathan.nezri@outlook.be
E-invoicing
Reachable via Peppol
Peppol ID 0208:1001941209
Also 9925:BE1001941209
Registered 10-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.